Market Exclusive

Analyst Downgrades – Hologic (NASDAQ:HOLX) Stock Gets Downgraded By Goldman Sachs Group, Inc. (The) from Conviction-Buy to Buy

Analyst Ratings For Hologic (NASDAQ:HOLX)

Today, Hologic (NASDAQ:HOLX) stock was downgraded by Goldman Sachs Group, Inc. (The) from Conviction-Buy to Buy.

There are 3 hold ratings, 10 buy ratings on the stock.

The current consensus rating on Hologic (NASDAQ:HOLX) is Buy (Score: 2.77) with a consensus target price of $48.83 per share, a potential 11.82% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Hologic (NASDAQ:HOLX)
Hologic (NASDAQ:HOLX) has insider ownership of 0.79% and institutional ownership of 94.32%.

Recent Trading Activity for Hologic (NASDAQ:HOLX)
Shares of Hologic closed the previous trading session at 43.67 down -0.33 -0.75% with 6,896,682 shares trading hands.

Exit mobile version